We provide below mentioned services in Phase II / III / IV drug and medical device studies, stem cell therapy – regenerative medicines, Non Interventional / Observational Studies, Registry & Epidemiological Studies and Disease Surveillance Programs in various therapeutic areas. We have also expanded our services to BA/BE and Phase I Studies through strategic alliances with other CROs.
We ensure to deliver the project within allocated budget and defined timeline through meticulous planning and precise coordination without compromising the quality, patient safety and confidentiality.
We diligently endeavor to ensure culmination of the Clinical Development projects within allocated budget and defined timelines through meticulous planning and synergistic coordination without compromising the quality, patient safety and confidentiality.
Site Identification, Feasibility Assessment and Selection
Recruitment of investigators through our direct contact and existing Investigator Database
Subject Recruitment Plans and Implementation
Investigators Meeting
Trial Master File - Essential Documents Development
Obtain IRB approval
Site Initiation
Training of all study personnel on protocols, Standard Operating Procedures (SOPs), Good Clinical
Practices (GCPs) and all aspects of study management
We assist Pharmaceutical Companies/Healthcare Organization in obtaining regulatory clearances after thoroughly understanding the Scientific literature/documents related to the Product/NCE/NBE/Device under consideration :
Drug Controller General of India (DCGI) Approval
Regulatory Dossier Compilation, Communication and application
Regulatory Approval from DCGI for New Drugs, Medical Devices
Directorate General of Foreign Trade (DGFT) Licenses
DGFT Export License for Biological Specimen
Import/T-license for New Drugs/Devices or Materials
Indian Council of Medical Research (ICMR) Clearances
Dossier Preparation, Communication and application for Vaccines/Biological Drugs /Cell
Therapy/ Investigators Initiated or Collaborative Studies.